ArticleLeukemia2022

Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia.

Simona Soverini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.